Globus Medical Inc.

NYSE: GMED · Real-Time Price · USD
60.55
0.53 (0.88%)
At close: Aug 15, 2025, 3:59 PM
59.33
-2.01%
After-hours: Aug 15, 2025, 07:06 PM EDT

Globus Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
745.34M 598.12M 657.29M 625.71M 629.69M 606.67M 616.53M 383.64M 291.62M 276.69M 274.5M 254.15M 263.65M 230.55M 250.02M 229.72M 251.02M 227.34M
Cost of Revenue
278.95M 195.4M 173.98M 300.59M 289.75M 271.16M 265.49M 135.39M 76.47M 70.83M 70.59M 65.5M 68.47M 59.17M 61.8M 58.55M 63.85M 55.03M
Gross Profit
466.39M 402.72M 483.32M 325.11M 339.94M 335.5M 351.05M 248.25M 215.14M 205.86M 203.91M 188.65M 195.18M 171.38M 188.22M 171.17M 187.17M 172.32M
Operating Income
76.11M 97M 60.27M 48.1M 49.62M 8M 10.12M 404K 66.21M 56.4M 54.03M 59.7M 67.78M 46.45M 18.2M 53.33M 45.88M 54.55M
Interest Income
n/a 1.68M n/a n/a n/a n/a n/a 7.92M 8.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
188.17M 103.67M 24.67M 57.03M 47.58M -8.56M 25M 2.54M 74.67M 63.19M 62.12M 61.47M 70.54M 48.9M 19.83M 54.45M 48.93M 57.19M
Net Income
202.85M 75.46M 26.5M 51.84M 31.76M -7.12M 15.03M 998K 57.71M 49.13M 50.06M 47.43M 54.59M 38.08M 15.11M 47.21M 41.55M 45.33M
Selling & General & Admin
303.62M 242.8M 253.48M 240.74M 238.12M 248.71M 244.72M 156.21M 120.07M 122.42M 118.08M 106.58M 106.72M 100.75M 106.56M 96.44M 107.25M 97.89M
Research & Development
39.95M 33.06M 33.41M 35.38M 37.7M 44.67M 52.25M 29.33M 21.35M 21.08M 19.51M 18.7M 17.39M 17.41M 51.02M 15.85M 15.55M 14.92M
Other Expenses
-3.42M 29.86M 94.02M n/a n/a n/a 43.95M 62.31M 716K 5.96M 12.3M 74K 4.39M 4.51M 143K -84K 307K 214K
Operating Expenses
340.16M 305.72M 380.9M 276.12M 275.82M 293.38M 340.93M 247.84M 145.96M 149.46M 149.88M 129.6M 128.51M 122.67M 162.14M 116.87M 127.42M 117.59M
Interest Expense
693K n/a -815K 775K 2.33M 1.89M 2.58M n/a 8.29M n/a n/a n/a 2.48M 2.54M 1.94M 2.1M 2.54M 2.71M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
619.11M 501.12M 597.02M 576.71M 580.07M 598.67M 606.41M 383.24M 222.44M 220.28M 220.47M 195.1M 196.98M 181.84M 223.93M 175.42M 191.27M 172.62M
Income Tax Expense
-14.67M 28.21M -1.84M 5.2M 15.82M -1.44M 9.96M 1.54M 16.96M 14.06M 12.05M 14.03M 15.95M 10.81M 4.72M 7.24M 7.39M 11.87M
Shares Outstanding (Basic)
135.21M 136.76M 136.73M 135.62M 135.19M 135.36M 137.88M 113.54M 100.37M 100.28M 99.97M 99.65M 100.67M 101.6M 101.5M 101.1M 100.45M 99.87M
Shares Outstanding (Diluted)
136.5M 139.77M 139.71M 138.06M 136.98M 135.36M 139.02M 115.25M 101.78M 102.2M 102.21M 101.42M 102.88M 104.08M 104.19M 104.42M 103.47M 102.42M
EPS (Basic)
1.50 0.55 0.19 0.38 0.23 -0.05 0.11 0.01 0.57 0.49 0.50 0.48 0.54 0.37 0.15 0.47 0.41 0.45
EPS (Diluted)
1.49 0.54 0.19 0.38 0.23 -0.05 0.11 0.01 0.57 0.48 0.49 0.47 0.53 0.37 0.14 0.45 0.40 0.44
EBITDA
258.8M 164.13M 192.76M 115.94M 113.5M 48.6M 98.74M 86.34M 87.25M 75.87M 78.73M 76.63M 87.47M 65.55M 42.92M 71.05M 68.06M 71.89M
EBIT
188.17M 98.06M 124.53M 49M 49.92M -6.66M 25.95M 48.95M 69.18M 57.76M 61.82M 59.05M 70.54M 48.71M 26.09M 54.3M 48.93M 54.73M
Depreciation & Amortization
70.63M 66.07M 68.23M 66.95M 63.59M 55.26M 71.16M 37.39M 18.07M 18.11M 16.91M 17.58M 16.93M 16.84M 16.83M 16.75M 19.13M 17.16M